Clinical observation of Jianpi Bushen Xiezhuo fang decoction for the intermittent gout patients with Pixu Shizhu zhen

Chongqing Hospital of Traditional Chinese Medicine,0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•A) Patients who have met the classification criteria of acute gout arthritis in the past and have been diagnosed as gout, but have no obvious joint symptoms, still high blood uric acid, no subcutaneous tophi and chronic kidney damage. Since the target value for lowering uric acid in patients with gout is <360umol/ L , uric acid >360umol/L can be included in the group.
•B) TCM syndrome type conforms to the diagnosis criteria of spleen deficiency and dampness resistance syndrome.
•C) Aged between 18 and 75.
•D) Did not take any western medicine for lowering uric acid 2 weeks before enrollment.
•E) Willing to use the program and sign informed consent for clinical observation.

•A) Consistent with intermittent gout diagnosis, but blood uric acid =360umol/L.
•B) patients with serious cardiovascular and cerebrovascular diseases, liver and kidney diseases, endocrine and digestive diseases, and mental diseases.
•C) patients with other diseases whose therapeutic drugs (such as losartan, aspirin enteric-coated tablets, anti-tuberculosis tablets, etc.) affect the blood uric acid level.
•D) those who are taking proprietary Chinese medicine or Traditional Chinese medicine with similar efficacy.
•E) Patients with acute or chronic infection, high fever, tuberculosis, acute suppurative, infectious or malignant tumor.
•F) pregnant or lactating women.
•G) Under 18 or over 75 years of age.
•H) Allergic constitution and drug allergy.

发起方

Chongqing Hospital of Traditional Chinese Medicine,